NewTimeSpace News: SSY GROUP (02005.HK) announced that its gadobutrol active pharmaceutical ingredient (API) has obtained registration approval from the National Medical Products Administration (NMPA) for use in marketed finished pharmaceutical products. As an MRI contrast agent, gadobutrol is indicated for adults and paediatric patients of all ages, applied in contrast-enhanced MRI and MR angiography examinations for lesions across all body parts.
NewTimeSpace News: SUNSHINE PHARMA (06887.HK) announced that Mr. Zhang Yushuai, controlling shareholder and non-executive director, intends to purchase shares worth HK$300 million to HK$600 million on the open market within the next six months, via himself or entities under his control. As of the announcement date, Mr. Zhang holds approximately 51.11% of issued shares through direct and indirect interests. Separately, the Company repurchased 817,500 shares on 20 July at a total consideration of around HK$26.36 million.
NewTimeSpace News: On July 20, Lung Fung Group announced that for the three months ended June 30, 2026, retail sales through stores reached approximately HK$829.3 million, up approximately 21.2% year-on-year from HK$684.2 million, with store count increasing from 27 to 31; sales at 25 comparable stores reached HK$740.5 million, representing a same-store sales increase of 10.3%. The Board attributed the growth mainly to increased customer traffic and expanded retail network coverage, though consecutive rainy days in June had some impact on sales. The data is unaudited and represents preliminary internal information only.
NewTimeSpace News: On July 21, Huaqin Technology announced that the reduction plans disclosed on June 23 by shareholders Hainan Qinyuan, Hainan Chuangjian, and Hainan Huaxiao had been fully implemented; the three shareholders reduced a combined total of 4,105,624 shares (0.27% of total shares) through centralized competitive bidding from July 15 to July 20, with total cash proceeds of approximately RMB 319 million, including Hainan Huaxiao's reduction of 2,727,464 shares for approximately RMB 211.5 million at a price range of RMB 73.53–81.14 per share. Post-reduction, Hainan Qinyuan holds 4.57%, Hainan Chuangjian holds 4.41%, and Hainan Huaxiao holds 4.08%; all shares were obtained pre-IPO and through capital reserve conversion.
SF HOLDING(06936.HK) will spend CNY 54 million to repurchase 1.6 million shares on Jul 20, 2026 .
NewTimeSpace News: On July 20, SMIT Holdings announced that its wholly-owned subsidiary, as seller, agreed to sell its 5 million shares in Xingji (representing 3.9529%) to Shengshi Zhida and Jiutian Shengshi for a total consideration of approximately RMB 63.25 million (RMB 57.05 million under Transfer A and RMB 6.20 million under Transfer B). Upon completion, the Seller will no longer hold any Xingji equity; the Group expects to record an unaudited pre-tax disposal loss of approximately USD 1.4 million, with net proceeds of approximately USD 9.2 million to be applied to investment opportunities in emerging technologies and areas synergistic with existing businesses. The transaction aligns with the Group's strategy to cease EDA product R&D and reduce its EDA investment portfolio, and constitutes a discloseable transaction as the applicable percentage ratios exceed 5% but are below 25%.
NewTimeSpace News: On July 20, GigaDevice announced that the Beijing Xiaomi Zhizao Equity Investment Fund, in which it invested RMB 200 million in 2022 (planned total fundraising of RMB 10 billion, currently fully raised), held a partners' meeting on July 20, 2026, resolving to extend the investment period from four years to five years from the first closing date, with the annual management fee during the extended period adjusted to 2% of unexited project costs allocated to the respective partner. The Company stated that this aligns with the fund's actual operational circumstances and will not materially affect its daily operations or financial conditions.
By the close of trading on Jul 20, 2026, Z.AI(02513.HK) saw a loss of 19.56% in its share price, closing at HKD 890.5. During the session, it reached an intraday high of HKD 1140 and touched an intraday low of HKD 878.
By the close of trading on Jul 20, 2026, MINIMAX-W(00100.HK) saw a loss of 10.6% in its share price, closing at HKD 193.1. During the session, it reached an intraday high of HKD 224.8 and touched an intraday low of HKD 191.
NewTimeSpace News: BAIYUNSHAN PH (00874.HK) announced that its subsidiary Baiyunshan General Pharmaceutical Factory has received the Proprietary Medicine Registration Certificate for 0.125g Cefalexin Capsules issued by the Macao SAR Pharmaceutical Administration Bureau. The product will be sold in Macao by Guangzhou Pharmaceutical International (Macao) under authorization, facilitating the Group’s overseas market expansion.
NewTimeSpace News: CICC announced on 20 July that the coupon rate of its publicly offered 2021 Corporate Bond (for Professional Investors) (Phase 3, Tranche 2) has been reduced from 3.39% to 1.30%.
NewTimeSpace News: FIRST CAP GP (01269.HK) announced on 20 July that the hearing for the winding-up petition has been adjourned to 9:30 a.m. on 26 October 2026. The Company is seeking legal advice and will release further announcements in due course. Its shares have been suspended from trading since April 2024.
On July 20, Hong Kong stocks rebounded, while the LLM sector exhibited sharp structural divergence. Shares tied to embodied AI and agent implementation surged, with XUNCE and SenseTime rising, and Chinasoft International skyrocketing 23% following a Token partnership with Moonshot AI; conversely, pure-play LLMs like ZHIPU AI and MiniMax continued their slide. On the corporate front, Moonshot AI sent IPO proposals aiming for a Hong Kong listing within six months as ARR reached USD 300 million; Tencent launched a standalone App for its efficiency agent WorkBuddy; and China Renaissance initiated coverage on Mininglamp, praising its Agentic AI monetization. The sector is accelerating its pivot toward commercialization and ecosystem monetization.
NewTimeSpace News: BEIJING ENT (00392.HK) announced on 20 July that it has completed the issuance of its Phase 1 publicly offered sci-tech innovation corporate bonds targeted at professional investors. Tranche 1 was not issued, while the 10-year Tranche 2 raised RMB1 billion at a final coupon rate of 2.09%. Issuance results have been disclosed on the SSE official website.
NewTimeSpace News: CGN POWER (01816.HK) announced on 20 July that its Cangnan and Huizhou nuclear power units have secured a fixed on-grid tariff of RMB 0.4153 per kWh (tax inclusive) during the period before they join power market trading; prices will be determined by market rules thereafter. Unit 1 of both projects entered commercial operation in April 2026, while Unit 2 of Huizhou and Cangnan are scheduled to commence commercial service in H2 2026 and 2027 respectively.
NewTimeSpace News: AM GROUP (01849.HK) announced it received a HKEX letter dated 10 July 2026, under which the Listing Committee resolved to cancel the Company’s listing pursuant to Listing Rule 6.01A(1), as the Company failed to satisfy all resumption guides and resume trading by 23 March 2026. Disagreeing with the ruling, the Company has applied to transfer the matter to the Listing Review Committee for review.
